Skip to main content
OpenTrials
Completed

NCT Number: NCT00782912

Postpartum Anemia and Postpartum Depression

Postpartum anemia (PPA) and Postpartum depression (PPD) are common afflictions affecting women after childbirth. Both disorders have a significant impact on women's health and functional status. Despite common symptoms and characteristics, a link between these entities has not been adequately studied. The objective of this study is to determine whether postpartum anemia is an independent risk factor for the development of postpartum depression. This prospective cohort study will include all women delivered by elective term cesarean delivery. Hemoglobin and iron levels will be measured, standardized questionnaires for assessment of PPD, functional status and lactation will be administered before discharge and at 3 & 6 weeks post partum. Hemoglobin levels at each time point will be analyzed for correlation with depressive symptoms, functional status and lactation success.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postpartum Depression Depression, Postpartum Depressive Disorder Female Urogenital Diseases and Pregnancy Complications Mental Disorders Mood Disorders Pregnancy Complications Puerperal Disorders Urogenital Diseases

Sex eligibility

Female

Study type

Observational

Primary location

St. Michael's Hospital

Toronto, Ontario, M5B1W8, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women after term elective cesarean section

Exclusion criteria

  • age < 16 years, preterm (< 37 weeks) delivery, multiple gestation, symptomatic anemia necessitating blood transfusion, significant fetal anomalies or infant not discharged with mother for other reason, preexisting severe chronic maternal illness, preexisting maternal depression and/or current use of antidepressants, other psychiatric illness (e.g. bipolar disease, schizophrenia) or preexisting hemoglobinopathy

Treatment and study plan

Primary outcomes

  1. Incidence of postpartum depression

    Time frame: 0-6 weeks postpartum

Secondary outcomes

  1. Mean Edinburgh Postnatal Depression Scale results

    Time frame: 0-6 weeks postpartum

  2. Functional status

    Time frame: 0-6 weeks postpartum

  3. Lactation success

    Time frame: 0-6 weeks postpartum

Sponsors and collaborators

Lead sponsor

Unity Health Toronto

Other

Registry information

Official study title

Is Postpartum Anemia an Independent Risk Factor for Development of Postpartum Depression?

Acronym: PPADS

Important dates

Study start
2008
Primary completion
2014
Study completion
2014
First posted
Oct 31, 2008
Registry last updated
Feb 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.